Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

L'Oreal Q1 Sales Up 9.4% - Quick Facts

L'Oreal (LRLCY.PK) said that on reported basis, Sales for the first-quarter were EUR 5.64 billion, up 9.4% from EUR 5.16 billion in the year ago quarter. On a Like-for-like basis, Sales for the quarter increased by 6.4%.

The Professional Products Division posted growth of 3.1% like-for-like in the first quarter, and 5.6% based on reported basis.

In the first quarter the Consumer Products Division achieved growth of 5.1% like-for-like, and 7.2% based on reported basis.

Click here to receive FREE breaking news email alerts for L'Oreal Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Beverages giant Coca-Cola Co. reported Tuesday a profit for the third quarter that decreased 14 percent from last year, despite higher worldwide volumes, reflecting a revenue drop. Adjusted earnings per share matched analysts' expectations, even as quarterly revenues missed their estimates. Following the announcement, the company's shares are trading more than five percent lower in early deals. Apple Inc. said Monday that its fourth quarter profit rose 13% from last year, driven by strong sales of its iPhones and Mac computers. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly sales. At the same time, the company gave an upbeat revenue forecast for the current quarter, which includes the all important holiday season. Programmable chipmaker Xilinx Inc. (XLNX) said Thursday after the markets closed that its second quarter profit rose 21% from last year, helped by higher revenue and better cost control. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue....
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.